Profession

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

How AI can be leveraged to improve patient acquisition.

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Enveda Biosciences Founder Viswa Colluru shares the lessons he has learned whilst charting the vast terra incognita of nature’s chemical structure

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.